Drawing for BEYOND BIOLOGICS

USPTO serial 87650417

BEYOND BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 5728864Status 702Registered
Filing date
Status date
Registration date
Apr 16, 2019
Examiner
BELL, MARLENE D
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BEYOND BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary A. Harris

Mary A. Harris MARY A. HARRIS, ATTORNEY AT LAW960 TORO STSAN LUIS OBISPO, CA 93401United States

Goods and services

ClassDescriptionStatusFirst use
044Medical services; medical consultations; providing medical therapies in the nature of blood therapy services; biomedical services, namely, collecting blood, blood components and stem cells for ultimate use in medical treatment and diagnosis; medical clinic providing anti-aging therapy; [ medical clinic providing medical aesthetic procedures in the nature of laser peels, ] botulinum toxin treatments, [ microdermabrasion, ] liposuction, [ vein treatments, vein therapy, ] cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care; medical clinic providing cellular therapy, namely, platelet rich plasma, stem cell, and amniotic fluid injections; medical clinic services; antiaging and regenerative medical services; medical clinic anti-aging services; medical services, namely, stem cell treatment, stem cell transplantation, and stem cell therapy; medical services using stem cells and stem cell products; medical services, namely, medical clinic providing regenerative medicine, sports medicine, concussion care, stem cell therapy services, plasma therapy, prolotherapy and non-surgical treatment services; medical services, namely, medical treatment related to sexual problems, consultation and evaluation of sexual related problems and providing regenerative therapy, platelet rich plasma, stem cell, customized formulation and medical treatment for sexual and hormonal dysfunction; collection of stem cells, biological cells, tissues and derivatives thereof; medical services in the field of orthopedic, sports medicine, and functional medicine; orthopedic surgery services; medical services, namely, pain treatments, platelet rich plasma therapy, and physical therapy; medical testing for diagnostic or treatment purposes; medical and physical rehabilitation services; health care services, namely, utilizing regenerative treatments including stem cell and/or platelet rich plasma therapy to relieve pain and improve function of the spine and joints in degenerative or injury situations; health and wellness clinics providing facial aesthetic procedures, platelet rich plasma therapies, and stem cell therapy; isolation and collection of human and allograft biological tissue, namely, blood, platelets, stem cells, and plasma, for use in homologous and autologous surgical, therapeutic and aesthetic procedures; medical equipment rental; custom fittings of medical equipment for others; providing medical therapies in the nature of infusion therapy services and blood therapy services; medical services; biomedical services, namely, collecting, preparing, concentrating, and injecting blood and human tissue components into a patient's diseased or injured joints to facilitate a natural healing process; providing medical procedures, namely, autologous stem cell transplantation; healthcare services, namely, delivering integrative health care services, stem cell therapies for regeneration of human tissues and cells; medical services relating to provision of stem cell therapies; medical consultation; stem cell collection, isolation, and administration services; providing a web site featuring medical information; medical services, namely, conducting holistic cell based therapy using autologous stem cells for the treatment of symptomatic degenerative diseases; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; medical consultations in the field of health and wellness, stem cell therapies and therapies for regeneration of human tissues and cells; medical treatment of human illnesses; biomedical services, namely, the collection of blood, blood components and stem cells for medical treatment and diagnosis; medical services in the nature of autologous blood therapiesACTIVENov 13, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 18, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 18, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 23, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Apr 16, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 16, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 11, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 21, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 20, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 30, 2019IUAFUSE AMENDMENT FILED—
Jan 30, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 7, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 12, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 12, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2018CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Feb 2, 2018ALIEASSIGNED TO LIE—
Feb 2, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 2, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 2, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 27, 2018DOCKASSIGNED TO EXAMINER—
Oct 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 21, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance